Nanoplatform based on SW480-derived exosome nanocarriers for efficient doxorubicin hydrochloride drug loading

The collection contains raw data generated during the successful isolation of exosomes from the human colon cancer cell line SW480 and their subsequent loading with doxorubicin hydrochloride as a drug-delivery nanoplatform. The size distribution of exosomes was obtained using the nanoparticle tracking assay (NTA). The loading of exosomes with doxorubicin was monitored using fluorescence spectroscopy and the standard addition method. The viability of HBE cells after exosomes loaded with doxorubicin uptake was evaluated using Alamar Blue assay.